{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T23:12:30Z","timestamp":1778368350668,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jns.2017.04.022","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T20:32:19Z","timestamp":1492029139000},"page":"219-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Ghrelin improves dystonia and tremor in patients with Rett syndrome: A pilot study"],"prefix":"10.1016","volume":"377","author":[{"given":"Kotaro","family":"Yuge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munetsugu","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumiko","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayoshi","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Nagamitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushiro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Orimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayasu","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyojiro","family":"Matsuishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2017.04.022_bb0005","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0387-7604(01)00193-0","article-title":"Guidelines for reporting clinical features in case with MECP2 mutations","volume":"23","author":"Kerr","year":"2001","journal-title":"Brain Dev."},{"key":"10.1016\/j.jns.2017.04.022_bb0010","first-page":"1","article-title":"An update clinically appreciable diagnostic criteria in Rett syndrome. Comments to Rett syndrome clinical criteria consensus panel satellite to European pediatric neurology society meeting, 11 September 2001","volume":"6","author":"Hagberg","year":"2002","journal-title":"Eur. J. Pediatr. Neurol."},{"key":"10.1016\/j.jns.2017.04.022_bb0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jns.2017.04.022_bb0020","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg1878","article-title":"Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized","volume":"7","author":"Bienvenu","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jns.2017.04.022_bb0025","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.braindev.2010.12.007","article-title":"Rett syndrome: the state of clinical and basic research, and future perspectives","volume":"33","author":"Matsuishi","year":"2011","journal-title":"Brain Dev."},{"key":"10.1016\/j.jns.2017.04.022_bb0030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1212\/WNL.40.2.293","article-title":"Extrapyramidal involvement in Rett's syndrome","volume":"40","author":"FitzGerald","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.04.022_bb0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mds.870050303","article-title":"Rett syndrome and associated movement disorders","volume":"5","author":"FitzGerald","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.04.022_bb0040","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/mds.22115","article-title":"Movement disorders in Rett syndrome: an analysis of 60 patients with detected MECP2 mutation and correlation with mutation type","volume":"23","author":"Temudo","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.04.022_bb0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/mds.22926","article-title":"Trihexyphenidyl for acute life-threatening episodes due to a dystonic movement disorders in Rett syndrome","volume":"25","author":"Gika","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.04.022_bb0050","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jns.2017.04.022_bb0055","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35051587","article-title":"A role for ghrelin in the central regulation of feeding","volume":"409","author":"Nakazato","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jns.2017.04.022_bb0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.00012.2004","article-title":"Ghrelin structure and function","volume":"85","author":"Kojima","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jns.2017.04.022_bb0065","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev-physiol-021113-170310","article-title":"The central nervous system sites mediating the orexigenic actions of Ghrelin","volume":"76","author":"Mason","year":"2014","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jns.2017.04.022_bb0070","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ijdevneu.2011.07.003","article-title":"Ghrelin levels are reduced in Rett syndrome patients with eating difficulties","volume":"29","author":"Hara","year":"2011","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.jns.2017.04.022_bb0075","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.braindev.2013.11.007","article-title":"Relation between circulating levels of GH, IGF-1, ghrelin and somatic growth in Rett syndrome","volume":"36","author":"Hara","year":"2014","journal-title":"Brain Dev."},{"key":"10.1016\/j.jns.2017.04.022_bb0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/eje.0.1500447","article-title":"Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects","volume":"150","author":"Akamizu","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jns.2017.04.022_bb0085","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1161\/01.CIR.0000149746.62908.BB","article-title":"Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure","volume":"110","author":"Nagaya","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2017.04.022_bb0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-07-0768","article-title":"Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite","volume":"158","author":"Akamizu","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jns.2017.04.022_bb0095","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1507\/endocrj.K09E-168","article-title":"Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study","volume":"56","author":"Hotta","year":"2009","journal-title":"Endocr. J."},{"key":"10.1016\/j.jns.2017.04.022_bb0100","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1053\/j.gastro.2009.12.058","article-title":"Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study","volume":"138","author":"Adachi","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jns.2017.04.022_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.surg.2009.11.026","article-title":"Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction","volume":"148","author":"Yamamoto","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.jns.2017.04.022_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035708","article-title":"Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"7","author":"Miki","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2017.04.022_bb0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/WNL.35.1.73","article-title":"Validity and reliability of a range scale for the primary torsion dystonia","volume":"35","author":"Burke","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.04.022_bb0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.21392","article-title":"Reliability of the Burke-Fahn-Marsden scale in a multicenter trial for dystonia","volume":"22","author":"Krystkowiak","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.04.022_bb0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/nur.4770130405","article-title":"A critical review of visual analogue scales in the measurement of clinical phenomena","volume":"13","author":"Wewers","year":"1990","journal-title":"Res. Nurs. Health"},{"key":"10.1016\/j.jns.2017.04.022_bb0130","first-page":"S89","article-title":"The neuropathology of the Rett syndrome","volume":"14","author":"Armstrong","year":"1992","journal-title":"Brain Dev."},{"key":"10.1016\/j.jns.2017.04.022_bb0135","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1073\/pnas.0912257106","article-title":"Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities","volume":"106","author":"Samaco","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.jns.2017.04.022_bb0140","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.expneurol.2008.05.006","article-title":"Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra","volume":"212","author":"Jiang","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jns.2017.04.022_bb0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2009.11.009","article-title":"Ghrelin prevents 1-methyl-4-phenylpyridium ion-induced cytotoxity through antioxidation and NF-kB modulation in MES23.5 cells","volume":"222","author":"Liu","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jns.2017.04.022_bb0150","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.neuroscience.2009.03.086","article-title":"Peripherally administered ghrelin induces bimodal effects on the mesolimbic dopamine system depending on food-consumptive states","volume":"161","author":"Kawahara","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2017.04.022_bb0155","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neuropharm.2012.11.022","article-title":"Food reward-sensitive interaction of ghrelin and opioid receptor pathways in mesolimbic dopamine system","volume":"67","author":"Kawahara","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2017.04.022_bb0160","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2012-4247","article-title":"Clinical review: the human experience with ghrelin administration","volume":"98","author":"Garin","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jns.2017.04.022_bb0165","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(08)60849-1","article-title":"Cardiorespiratory challenges in Rett's syndrome","volume":"371","author":"Julu","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2017.04.022_bb0170","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuropharm.2012.08.010","article-title":"Rett syndrome treatment in mouse models: searching for effective targets and strategies","volume":"68","author":"Ricceri","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jns.2017.04.022_bb0175","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2174\/15748847113086660069","article-title":"Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives","volume":"8","author":"Chapleau","year":"2013","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.jns.2017.04.022_bb0180","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1073\/pnas.1311141111","article-title":"Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome","volume":"111","author":"Khwaja","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jns.2017.04.022_bb0185","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1523\/JNEUROSCI.4373-15.2016","article-title":"Ghrelin-AMPK signaling mediates the neuroprotective effects of calorie restriction in Parkinson's disease","volume":"36","author":"Bayliss","year":"2016","journal-title":"J. Neurosci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17302551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17302551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T03:38:49Z","timestamp":1656041929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X17302551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":37,"alternative-id":["S0022510X17302551"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.04.022","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ghrelin improves dystonia and tremor in patients with Rett syndrome: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}